Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others), By Application (Clinical Research, Drug Discovery & Development, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizat
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others), By Application (Clinical Research, Drug Discovery & Development, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizat
For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.
One of the major advantages of cell-based assays is their ability to provide more physiologically relevant data compared to traditional biochemical assays. In traditional biochemical assays, the activity of a compound is measured in vitro using isolated enzymes or proteins. However, this approach does not take into account the complexity of the cellular environment, which can have a significant impact on the activity of a compound. Cell-based assays, on the other hand, provide a more realistic representation of the in vivo environment and can better predict the activity of a compound in vivo. Cell-based assays have a wide range of applications in drug discovery, toxicology, and basic research. In drug discovery, cell-based assays are used to screen large libraries of compounds for their ability to modulate specific cellular pathways or to inhibit the growth of cancer cells. In toxicology, cell-based assays are used to evaluate the potential toxicity of compounds and to identify compounds that may cause adverse effects. In basic research, cell-based assays are used to study cellular signaling pathways, protein-protein interactions, and gene expression. Another advantage of cell-based assays is their ability to provide a functional readout of the activity of a compound. In traditional biochemical assays, the activity of a compound is measured using indirect methods such as enzyme activity assays or binding assays. In contrast, cell-based assays provide a direct measure of the activity of a compound in a cellular context. Despite their advantages, cell-based assays also pose several challenges.
One of the major challenges is the variability in the behavior of cells in culture. Cells can exhibit significant variability in their growth rate, response to stimuli, and other properties. This variability can make it difficult to interpret the results of cell-based assays and to compare the activity of compounds across different assays. Another challenge of cell-based assays is their cost and complexity. Cell-based assays require specialized equipment, reagents, and expertise, which can be costly and time-consuming to develop and maintain. As cell-based assays rely on living cells, there can be a significant degree of variability in cell behavior, including growth rates, responses to stimuli, and other properties. This variability can make it difficult to interpret the results of cell-based assays and can lead to inconsistent outcomes. Ensuring the reproducibility of cell-based assays can be challenging due to variability in cell behavior and the complex nature of the assays. Standardizing assay protocols and reagents can help to improve the reproducibility of these assays and reduce variability, but this requires significant effort and collaboration among researchers and assay developers. The use of living cells in assays raises ethical and regulatory concerns, particularly when it comes to the use of stem cells and other sensitive cell types. Regulations surrounding the use of cell-based assays can vary by region and can impact the development and adoption of these technologies.
Growing Demand for Cell Based Assays Will Propel the Market Growth
During September 28, 2020–May 22, 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for influenza virus.
Increasing Number of Drug Discovery Activities Will Fuel the Market Growth
For instance, in May 2021, U.S. FDA granted Emergency Use Authorization (EUA) for the T-Detect COVID-19 routine T-cell test.
Recent Development
- For instance, in September 2022, researchers at the Fraunhofer Institute developed Proxidrugs to utilize a cells-based waste disposal system as a potential therapeutic option for infections, cancer, and Alzheimer’s disease.
- For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.
- For instance, in August 2022, LifeNet Health LifeSciences announced the launch of its new cell-based assay services to aid in drug discovery and development.
- Thermo Fisher Scientific launched the CellInsight NXT HCS platform in 2020. This platform enables researchers to perform automated, high-throughput imaging and analysis of cells for a range of applications, including drug discovery and toxicity testing.
- Molecular Devices launched the SpectraMax i3x microplate reader in 2021. This reader can be used for a range of assays, including cell viability, apoptosis, and protein expression. It offers several detection modes, including absorbance, fluorescence, and luminescence, and can perform kinetic measurements.
- NanoSurface Biomedical launched the NanoCulture plate in 2021. This product enables researchers to create and study 3D cell cultures at the nanoscale level, providing a more physiologically relevant model for drug discovery and toxicity testing.
- NanoCellect Biomedical launched the Tycho Cell Analysis System in 2021. This system can be used for the analysis of single cells, providing high-resolution images and quantitative data on cell size, shape, and phenotype. It can be used for a range of applications, including cell sorting and characterization.
Market Segmentation
The global cell-based assays market can be segmented by products and services, by application, by end user and by region. Based on products and services, the market can be segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others. Based on application, the market can be segmented into Clinical Research, Drug Discovery & Development, Others. Based on end user, the market can be differentiated into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global cell-based assays market on account of growing demand for identification and optimization of novel drug in the country.
Market Players
Report Scope
In this report, Global Cell Based Assays Market has been segmented into following categories, in addition to the industry trends which have also been detailed below
- Cell Based AssaysMarket, By Products & Services
o Reagents
o Assay Kits
o Microplates
o Probes & Labels
o Cell Lines
o Others
- Cell Based AssaysMarket, By Application
o Clinical Research
o Drug Discovery & Development
o Others
- Cell Based AssaysMarket, By End User
o Biotechnology & Pharmaceutical Companies
o Academic & Research Institutions
o Contract Research Organizations
- Cell Based AssaysMarket, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles
found at Customizations
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are found at for the report
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Global Cell Based Assays Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy